Lipocine Inc. (LPCN)
CIK 1535955 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Lipocine Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 11, 2026 | 8-K | 0001493152-26-042286 |
| Sep 10, 2026 | 8-K | 0001493152-26-042052 |
| Aug 21, 2026 | 8-K/A | 0001493152-26-039689 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0002050709-26-000023 |
| Aug 7, 2026 | 4 | 0001493152-26-036577 |
| Aug 7, 2026 | 3 | 0001493152-26-036573 |
| Aug 4, 2026 | 8-K | 0001493152-26-035913 |
| Aug 4, 2026 | 10-Q | 0001493152-26-035909 |
| Aug 3, 2026 | 8-K | 0001493152-26-035762 |
| Jun 30, 2026 | 4 | 0001493152-26-031377 |
| Jun 12, 2026 | 8-K | 0001493152-26-028429 |
| Jun 9, 2026 | S-8 | 0001493152-26-027923 |
| Jun 4, 2026 | 8-K | 0001493152-26-027209 |
| Jun 4, 2026 | 4 | 0001493152-26-027262 |
| Jun 4, 2026 | 4 | 0001493152-26-027261 |
| Jun 4, 2026 | 8-K | 0001493152-26-027266 |
| Jun 4, 2026 | 4 | 0001493152-26-027259 |
| May 26, 2026 | 8-K | 0001493152-26-025270 |
| May 19, 2026 | 8-K | 0001493152-26-024365 |
| May 18, 2026 | 8-K | 0001493152-26-024097 |
| May 15, 2026 | SCHEDULE 13G/A | 0002050709-26-000015 |
| May 15, 2026 | SCHEDULE 13G | 0001193125-26-227147 |
| May 7, 2026 | 8-K | 0001493152-26-021712 |
| May 7, 2026 | 10-Q | 0001493152-26-021637 |
| May 7, 2026 | 8-K | 0001493152-26-021638 |